JAMA Clinical Reviews

Interview with Esa M. Davis, MD, MPH, USPSTF member and coauthor of Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Screening for Hypertensive Disorders of Pregnancy Screening for Hypertensive Disorders of Pregnancy Hypertension Screening in Pregnancy Screening for High Blood Pressure Disorders During Pregnancy

Gilaad Kaplan, University of Calgary, discusses the latest information on ulcerative colitis including diagnostic tests, extra intestinal manifestations, skin conditions, treatment options, health maintenance needs, vaccine safety, prognosis, and life expectancy.

The podcast discusses the long-term cardiometabolic health risks for individuals with pregnancies complicated by gestational diabetes. It covers the importance of postpartum screening for gestational diabetes, screening recommendations and implications for pregnancy outcome, diabetes screening and cardiometabolic health after gestational diabetes, and recognizes gestational diabetes mellitus as a red flag for future cardiometabolic risks.

Interview with John B. Wong, MD, USPSTF member and coauthor of Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Preexposure Prophylaxis for the Prevention of HIV New USPSTF Guidelines for HIV Preexposure Prophylaxis Preexposure Prophylaxis to Prevent Acquisition of HIV Preventing HIV With PrEP

The podcast discusses the importance of HPV screening and vaccination in preventing cervical cancer. It highlights the availability of tools like HPV vaccines and tests, and the potential to eliminate cervical cancer as a public health problem. It emphasizes the importance of HPV vaccination for all children and effective screening guidelines. The frequency of cervical cancer screenings is discussed, along with the screening needs of certain individuals. The podcast also addresses health inequities and the potential of self-sampling as a screening method. New management guidelines for abnormal HPV and pap tests are also covered.

In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease. Related Content: Amyloid-Targeting Monoclonal Antibodies for Alzheimer Disease Donanemab in Early Symptomatic Alzheimer Disease

Interview with Katrina E. Donahue, MD, MPH, USPSTF member and coauthor of Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Folic Acid Supplementation to Prevent Neural Tube Defects Folic Acid Supplementation to Prevent Neural Tube Defects Fully Effective Folic Acid Fortification Reaffirming Recommendations for Folic Acid Supplementation Folic Acid to Prevent Neural Tube Defects

JAMA Associate Editor David L. Simel, MD, MHS, discusses the latest European Society of Intensive Care Medicine (ESICM) Guidelines on Acute Respiratory Distress Syndrome, which were released in June 2023, with Derek C. Angus, MD, MPH, University of Pittsburgh. Related Content: Caring for Patients With Acute Respiratory Distress Syndrome

Interview with Li Li, MD, PhD, MPH, USPSTF member and coauthor of Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Screening for Lipid Disorders in Children and Adolescents Screening for Lipid Disorders in Children and Adolescents Still “on the Fence” About Universal Childhood Lipid Screening Screening for Lipid Disorders in Children and Adolescents

The incidence of Cushing syndrome due to endogenous overproduction of cortisol is 2 to 8 people per million annually. JAMA Deputy Editor Mary M. McDermott, MD, discusses diagnosis, management, and treatment of this condition with authors Martin Reincke, MD, from University of Munich, and Maria Fleseriu, MD, from Oregon Health and Science University. Related Content: Cushing Syndrome